Longboard Pharmaceuticals, Inc. — Net Income by Fiscal Year
4 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/38df6818-5a96-4764-af31-89bcbec59219/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2023 | $-54.4M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-029952 |
| FY 2022 | $-43.9M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-005832 |
| FY 2021 | $-27.8M | 2021-01-01 – 2021-12-31 | evidence 0000950170-22-002818 |
| FY 2020 | $-14.4M | 2020-01-04 – 2020-12-31 | evidence 0000950170-22-002818 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Longboard Pharmaceuticals, Inc. — all facts · Operating Income